Compare FUND & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUND | LAB |
|---|---|---|
| Founded | 1988 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.2M | 326.2M |
| IPO Year | N/A | 2008 |
| Metric | FUND | LAB |
|---|---|---|
| Price | $10.61 | $0.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 25.1K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ 0.93 | 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | $11.56 | ★ $2.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.97 | $0.63 |
| 52 Week High | $10.99 | $1.72 |
| Indicator | FUND | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 42.91 |
| Support Level | $9.87 | $0.63 |
| Resistance Level | $10.96 | $1.02 |
| Average True Range (ATR) | 0.17 | 0.04 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 15.93 | 55.38 |
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, the Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.